What is the address of DOKTER PETER SCHATTEMAN-UROLOGIE?

The registered office of DOKTER PETER SCHATTEMAN-UROLOGIE is located at Bremstraat 6, 1702 Dilbeek.

Is DOKTER PETER SCHATTEMAN-UROLOGIE still active?

Yes. According to the CBE (29 September 2026) DOKTER PETER SCHATTEMAN-UROLOGIE is active, legal situation “Normale toestand”, started on 13 December 2006.

Is DOKTER PETER SCHATTEMAN-UROLOGIE registered on Peppol?

No, DOKTER PETER SCHATTEMAN-UROLOGIE is currently not registered on the Peppol network.

What is the enterprise number of DOKTER PETER SCHATTEMAN-UROLOGIE?

The enterprise number of DOKTER PETER SCHATTEMAN-UROLOGIE is BE0885629695.

When was DOKTER PETER SCHATTEMAN-UROLOGIE founded?

DOKTER PETER SCHATTEMAN-UROLOGIE was founded on 13 December 2006.

Who are the directors of DOKTER PETER SCHATTEMAN-UROLOGIE?

According to the 2025 annual accounts, the directors of DOKTER PETER SCHATTEMAN-UROLOGIE are: Peter SCHATTEMAN.

Is DOKTER PETER SCHATTEMAN-UROLOGIE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 13 December 2006; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did DOKTER PETER SCHATTEMAN-UROLOGIE make in 2025?

DOKTER PETER SCHATTEMAN-UROLOGIE posted a profit after taxes of € 362,829 in financial year 2025.

What is the revenue of DOKTER PETER SCHATTEMAN-UROLOGIE?

As a small company, DOKTER PETER SCHATTEMAN-UROLOGIE is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 579,982.

DOKTER PETER SCHATTEMAN-UROLOGIE (Private Limited)

Dossier DOKTER PETER SCHATTEMAN-UROLOGIE, printed on 29 September 2026 from databakkes.be/en/0885629695/dokter-peter-schatteman-urologie. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Not on Peppol Peppol

Not registered in the Peppol network, mandatory for VAT-liable companies since 1 January 2026.

Financials

Financial year 2025

DOKTER PETER SCHATTEMAN-UROLOGIE from Dilbeek, company number BE0885629695, closed financial year 2025 with a result of € 362,829 after tax. For that financial year DOKTER PETER SCHATTEMAN-UROLOGIE recorded a gross margin of € 579,982 and equity of € 2 million. Compared with financial year 2024, the result moved from € 349,907 to € 362,829. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 15, 2026.

What it is worth Growing

€ 2 million

▲ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 362,829

▲ 4% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 693,341

▲ 85% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 239,127 paid out

66 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 44,120

▼ 30% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 212

▼ 93% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 28,787

▲ 1% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 752,242 Gross margin 2022: € 752,242 First fiscal year in the series	€ 612,124 Gross margin 2023: € 612,124 ▼ 19% vs 2022 (€ 752,242) Unfavourable step	€ 558,436 Gross margin 2024: € 558,436 ▼ 9% vs 2023 (€ 612,124) Unfavourable step	€ 579,982 Gross margin 2025: € 579,982 ▲ 4% vs 2024 (€ 558,436) Favourable step	▲ 4%
Profit after taxes	€ 502,104 Profit after taxes 2022: € 502,104 First fiscal year in the series	€ 377,457 Profit after taxes 2023: € 377,457 ▼ 25% vs 2022 (€ 502,104) Unfavourable step	€ 349,907 Profit after taxes 2024: € 349,907 ▼ 7% vs 2023 (€ 377,457) Unfavourable step	€ 362,829 Profit after taxes 2025: € 362,829 ▲ 4% vs 2024 (€ 349,907) Favourable step	▲ 4%
Equity	€ 1,625,387 Equity 2022: € 1,625,387 First fiscal year in the series	€ 1,747,123 Equity 2023: € 1,747,123 ▲ 7% vs 2022 (€ 1,625,387) Favourable step	€ 1,831,082 Equity 2024: € 1,831,082 ▲ 5% vs 2023 (€ 1,747,123) Favourable step	€ 1,954,784 Equity 2025: € 1,954,784 ▲ 7% vs 2024 (€ 1,831,082) Favourable step	▲ 7%
Total debts	€ 237,403 Total debts 2022: € 237,403 First fiscal year in the series	€ 148,535 Total debts 2023: € 148,535 ▼ 37% vs 2022 (€ 237,403) Favourable step	€ 31,794 Total debts 2024: € 31,794 ▼ 79% vs 2023 (€ 148,535) Favourable step	€ 153,557 Total debts 2025: € 153,557 ▲ € 121,763 vs 2024 (€ 31,794) Unfavourable step	▲ € 121,763
Cash	€ 640,577 Cash 2022: € 640,577 First fiscal year in the series	€ 111,866 Cash 2023: € 111,866 ▼ 83% vs 2022 (€ 640,577) Unfavourable step	€ 374,305 Cash 2024: € 374,305 ▲ 235% vs 2023 (€ 111,866) Favourable step	€ 693,341 Cash 2025: € 693,341 ▲ 85% vs 2024 (€ 374,305) Favourable step	▲ 85%
Land & buildings	€ 256,471 Land & buildings 2022: € 256,471 First fiscal year in the series	€ 201,251 Land & buildings 2023: € 201,251 ▼ 22% vs 2022 (€ 256,471) Unchanged	€ 149,186 Land & buildings 2024: € 149,186 ▼ 26% vs 2023 (€ 201,251) Unchanged	€ 91,249 Land & buildings 2025: € 91,249 ▼ 39% vs 2024 (€ 149,186) Unchanged	▼ 39%
Retained profit	€ 1,612,987 Retained profit 2022: € 1,612,987 First fiscal year in the series	€ 1,734,723 Retained profit 2023: € 1,734,723 ▲ 8% vs 2022 (€ 1,612,987) Favourable step	€ 1,818,682 Retained profit 2024: € 1,818,682 ▲ 5% vs 2023 (€ 1,734,723) Favourable step	€ 1,942,384 Retained profit 2025: € 1,942,384 ▲ 7% vs 2024 (€ 1,818,682) Favourable step	▲ 7%
Dividend	€ 226,814 Dividend 2022: € 226,814 First fiscal year in the series	€ 255,721 Dividend 2023: € 255,721 ▲ 13% vs 2022 (€ 226,814) Unchanged	€ 265,948 Dividend 2024: € 265,948 ▲ 4% vs 2023 (€ 255,721) Unchanged	€ 239,127 Dividend 2025: € 239,127 ▼ 10% vs 2024 (€ 265,948) Unchanged	▼ 10%
Bank debt	€ 50,143 Bank debt 2022: € 50,143 First fiscal year in the series	€ 3,955 Bank debt 2023: € 3,955 ▼ 92% vs 2022 (€ 50,143) Favourable step	€ 0 Bank debt 2024: € 0 ▼ 100% vs 2023 (€ 3,955) Favourable step	€ 0 Bank debt 2025: € 0 Unchanged (€ 0) Unchanged
Balance sheet total	€ 1,862,790 Balance sheet total 2022: € 1,862,790 First fiscal year in the series	€ 1,895,658 Balance sheet total 2023: € 1,895,658 ▲ 2% vs 2022 (€ 1,862,790) Unchanged	€ 1,862,876 Balance sheet total 2024: € 1,862,876 ▼ 2% vs 2023 (€ 1,895,658) Unchanged	€ 2,108,341 Balance sheet total 2025: € 2,108,341 ▲ 13% vs 2024 (€ 1,862,876) Unchanged	▲ 13%

Key figures of DOKTER PETER SCHATTEMAN-UROLOGIE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DOKTER PETER SCHATTEMAN-UROLOGIE?

What happened at DOKTER PETER SCHATTEMAN-UROLOGIE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 15, 2026 New annual accounts for financial year 2025: profit of € 362,829 (▲ 4% vs 2024). Source: NBB ↗
Dec 13, 2006 Start of the company according to the CBE. KBO
Nov 30, 2006 New establishment in Dilbeek. KBO
2006 Peter SCHATTEMAN became a director. NBB

In short

From € 502,104 profit in 2022 to € 362,829 profit in 2025.

Paid € 713,291 in corporate taxes since 2022.

Best year ever: 2022, with € 502,104 profit.

Paid out € 987,611 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at DOKTER PETER SCHATTEMAN-UROLOGIE? We notify you, reason included.

Follow DOKTER PETER SCHATTEMAN-UROLOGIE

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit